Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS · BSE: 544222 · Pharmaceuticals & Biotechnology · 35 announcements

Share price
₹826.50
Market cap
₹13,009 Cr
Revenue (annual)
₹4,359 Cr
Net profit (annual)
₹255.2 Cr
P/E (TTM)
44.6×Sector 47.4×
Promoter holding
75.26%+0.00% QoQ
FII holding
1.91%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:06 IST NSE
Adverse Business Impact

Akums Drugs & Pharmaceuticals Adverse Business Impact

Akums Drugs resumed 100% operations following a four-day disruption at Haridwar sites. The incident delayed ₹20 Crore in supply, but production loss recovery is expected.

Value
₹20.00 Cr
14:32 IST NSE
Adverse Business Impact

Akums Drugs & Pharmaceuticals Adverse Business Impact

Akums Drugs resumed over 70% of Haridwar operations following industry-wide labor unrest. Normalcy is being restored with local authorities after disruptions triggered by minimum wage reviews.

16:20 IST NSE
Adverse Business Impact

Akums Drugs & Pharmaceuticals Adverse Business Impact

Akums Drugs reported temporary operational disruptions at its Haridwar plants due to labor unrest. Management is actively negotiating with workers and local authorities to resolve the issue.